What is the Impact Factor of Clinical Genitourinary Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical Genitourinary Cancer is 2.40, ranking in quartile Q3 of Web of Science (SCIE).

Is Clinical Genitourinary Cancer indexed in Web of Science or Scopus?

Yes, Clinical Genitourinary Cancer is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.050 (Q1) and an H-index of 62.

Who publishes Clinical Genitourinary Cancer and what is the Article Processing Charge (APC)?

Clinical Genitourinary Cancer is published by Elsevier. The estimated Article Processing Charge (APC) is approximately $3,343 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical Genitourinary Cancer?

The official ISO-4 abbreviation of Clinical Genitourinary Cancer is "CLIN GENITOURIN CANC" with common acronym "cguc". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q1SCImago #4,516Hybrid

Clinical Genitourinary Cancer

Acronym:cguc

•

Abbreviation (ISO):CLIN GENITOURIN CANC

•

Identifier (ISSN):1558-7673(Print)/1938-0682(Online)

•

Publisher:Elsevier

Official Website Submission Portal Compare

Clarivate IF (2026)

2.4↓ -0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Genitourinary Cancer

WoS Q3

Annual Impact Factor Metric

Current (2026):2.4

Scopus SJR & RankScopus Q1

1.05

#4,516

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

62 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate4.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

126articles/year

19.53% Gold OA•95.49% Original Research

Aims & Scope

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Topics Covered (Recognized by AI)

MedicineInternal medicine93.9%Biology92%Genetics90%Cancer80.1%Oncology74.5%Pathology71.1%Surgery65%Mathematics41.2%Statistics37.8%Prostate cancer34.7%Urology34.2%Chemistry28.4%Endocrinology28%Renal cell carcinoma27.9%Chemotherapy27.2%Prostate26%Radiology25.4%Biochemistry22.1%Immunology21.5%Confidence interval20.9%

Primary Research Areas

Medicine Urology & Nephrology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank214/333

IndexSCIE

JCRSCIE2026

UROLOGY & NEPHROLOGY

Rank57/134

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank133/333

IndexSCIE

JCISCIE2026

UROLOGY & NEPHROLOGY

Rank53/134

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	214/333	Q3
UROLOGY & NEPHROLOGY	JCRSCIE	57/134	Q2
ONCOLOGY	JCISCIE	133/333	Q2
UROLOGY & NEPHROLOGY	JCISCIE	53/134	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.4

Articles / Year168

Total Citations38

2025

IF2.7

Articles / Year194

Total Citations376

2024

IF2.3

Articles / Year269

Total Citations1,159

2023

IF3.2

Articles / Year175

Total Citations1,390

2022

IF3.121

Articles / Year180

Total Citations1,518

Year	Impact Factor	Articles / Year	Total Citations
2026	2.4	168	38
2025	2.7	194	376
2024	2.3	269	1,159
2023	3.2	175	1,390
2022	3.121	180	1,518
2021	2.872	150	1,891
2020	2.695	142	2,509
2019	2.45	261	4,405
2018	2.539	212	4,234
2017	—	251	4,645
2016	—	232	4,650
2015	—	190	3,460

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,516Scopus Q1SCImago Profile

Scopus Coverage:2005-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.05

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.51

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,343 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,523

3-Year Documents606

Citable Documents593

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate29.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

UrologyQ1

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Genitourinary Cancer (acronym: cguc, abbr: CLIN GENITOURIN CANC, ISSN: 1558-7673) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in United States since 2005. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.050 (Q1), an H-index of 62.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 126 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,343 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.